Back to search

Article

Blockade of IL-6 inhibits tumor immune evasion and improves anti–PD-1 immunotherapy

2022-03-09

Abstract excerpt

<h4>Background: </h4> Long-standing inflammatory bowel disease predisposes to the development of colorectal cancer (CRC). Interleukin (IL) -6, a pivotal link between chronic inflammation and tumor progression, has recently been recognized as a potential target. The effect of IL-6 on proliferation and metastasis of CRC by activating STAT3 pathway has been widely demonstrated in recent years, but few on mediating tu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5e88efb3-e16f-5c77-929f-bdb402d5f515
DOI
10.21203/rs.3.rs-1420368/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Blockade of IL-6 inhibits tumor immune evasion and improves anti–PD-1 immunotherapyDOI 10.21203/rs.3.rs-1420368/v1
Select a neighboring publication to make it the new centre.